首页 | 本学科首页   官方微博 | 高级检索  
检索        

依帕司他对糖尿病患者心率变异性影响的评价
引用本文:林令华,许金华,孟凡霞,李志改,于军会,杨华.依帕司他对糖尿病患者心率变异性影响的评价[J].中国医院用药评价与分析,2006,6(5):274-276.
作者姓名:林令华  许金华  孟凡霞  李志改  于军会  杨华
作者单位:江苏省连云港东海县人民医院,连云港市,222300
基金项目:江苏省卫生厅临床药学科研项目
摘    要:目的:评价依帕司他对糖尿病患者心率变异性的影响。方法:收集患者93例,分为治疗组和对照组,治疗组患者接受依帕司他50mg,每日3次治疗,服用4周,运用24小时动态心电图检测所有患者在治疗前后心率变异性指标的变化,明确依帕司他治疗糖尿病心脏自主神经病变的疗效。结果:治疗组心率变异性各项指标治疗4周后较治疗前有显著提高,自主神经症状明显好转,与对照组比较有显著意义。结论:依帕司他治疗糖尿病心脏自主神经病变的疗效显著,可以改善患者心率变异性。

关 键 词:依帕司他  糖尿病  心脏自主神经病变  心率变异性
文章编号:1672-2124(2006)05-0274-03
修稿时间:2006年5月23日

Evaluation about Effect of Epalrestat on Heart Rate Variability in Patients with Diabetes
LIN Linghua,XU Jinhua,MENG Fanxia,LI Zhigai,YU Junhui,YANG Hua.Evaluation about Effect of Epalrestat on Heart Rate Variability in Patients with Diabetes[J].Evaluation and Analysis of Drug-Use in Hospital of China,2006,6(5):274-276.
Authors:LIN Linghua  XU Jinhua  MENG Fanxia  LI Zhigai  YU Junhui  YANG Hua
Abstract:OBJECTIVE:To evaluate the effect of epalrestat on heart rate variability(HRV) in diabetes.METHODS: A total of 93 patients were assigned to receive 50mg epalrestat t.i.d for four weeks or placebo.The change of the HRV parameters of all patienes was detected using 24-hour DCG(dynamic electrocardiogram),and the efficacy of epalrestat on heart rate variability(HRV) in diabetics with cardiac autonmic neuropathy was investigated.RESULTS: In the treatment group,HRV parameters had a significant improvement four weeks after receiving treatment as against before treatment,cardiac autonmic neuropathy improved significantly,and there were significances as compared with control group.CONCLUSION: Epalrestat is effective for cardiac autonmic neuropathy in patients with diabetes and it can improve patients' HRV.
Keywords:hpalrestat  diabetes  cardiac autonmic ncuropathy  heart rate variability(HRV)
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号